Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1605081000001110 | Acalabrutinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1605091000001112 | Acalabrutinib (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acalabrutinib | Is a | Substance with non-specific protein-tyrosine kinase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Calquence 100mg capsules (Imported (United States)) 60 capsule | Has specific active ingredient | False | Acalabrutinib | Inferred relationship | Existential restriction modifier | |
| Calquence 100mg capsules (Imported (United States)) | Has specific active ingredient | False | Acalabrutinib | Inferred relationship | Existential restriction modifier | |
| Acalabrutinib 100mg capsules 60 capsule | Has specific active ingredient | False | Acalabrutinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR